Phendimetrazine-Induced Persistent Psychosis: A Case Report

Vartak, Sukanya; Varadarajulu, Rachel Natasha; Sadeghzadeh, M; Bodic, Maria

doi:10.3928/00485713-20210909-01

Cited by 1 publication

(2 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Medical narcotic appetite suppressants should be administered with prudence, adhering to the healthcare provider’s prescription guidelines. 8 13 In particular, the four medications sanctioned for short-term use are generally recommended for up to 4 weeks but can be extended to a maximum of 12 weeks if required. Despite these recommendations, the 2022 report from the Ministry of Food and Drug Safety revealed that 1.6 million patients were prescribed medical narcotic appetite suppressants, with a substantial portion receiving prescriptions extending beyond 3 months.…”

Section: Discussionmentioning

confidence: 99%

“…3 Long-term administration of these medications has been associated with cardiovascular complications and psychological disorders, such as depression and suicidal tendencies. 6 7 8 A recent KDCA report highlighted an increase in instances of utilization extending beyond 3 months, underscoring inappropriate prescribing habits. 9 Consequently, the long-term use of medical narcotic appetite suppressants has led to amplified adverse effects, including the risk of dependency and psychological disturbances.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Analysis of Prescription Trends for Narcotic Appetite Suppressants: Utilizing the Narcotics Information Management System

Oh,

Han

2024

Yonsei Med J

View full text Add to dashboard Cite

Purpose The aim of this study was to systematically analyze the prescription trends of medical narcotic appetite suppressants in South Korea. Materials and Methods Data was extracted from the Narcotics Information Management System dataset from 2020, which encompasses nationwide information concerning the use of medical narcotics. The selected variables for this study included the types of prescribed medical narcotic appetite suppressants, gender, age, region, and the category of medical institution. Regional prescription trends were compared by utilizing the defined daily doses for statistical purposes (S-DDD). Results The prescription of medical narcotic appetite suppressants was predominantly for females (94%), with the highest prescription rates identified in the 30–40 age group. The majority of these prescriptions were dispensed by clinics. Within the category of narcotic appetite suppressants, phentermine and phendimetrazine were found to have higher prescription rates. Notably, the region of Daegu recorded the highest S-DDD value (12.66) in phentermine consumption. Conclusion Our findings underscore the need for governmental policy and guidance to address the risks linked to the long-term use of medical narcotic appetite suppressants. This is crucial to ensure their safe and efficacious prescription and administration.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%